Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-06

Clinical Trial Update: Organoid-guided Personalized Treatment of Pleural Effusion

View source ↗

Summary

Clinical trial update indicates that organoid-guided personalized treatment for pleural effusion in lung cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Lung Cancer | Status: RECRUITING